Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-3-19
pubmed:abstractText
Hypotension refractory to maximal doses of alpha-adrenergic drugs after cardiac operations employing cardiopulmonary bypass (CPB) has been referred as "vasoplegic syndrome." Vasopressin has been used for its therapy with encouraging results.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0886-0440
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
485-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12643457-Adrenergic alpha-Agonists, pubmed-meshheading:12643457-Adrenergic alpha-Antagonists, pubmed-meshheading:12643457-Aged, pubmed-meshheading:12643457-Aged, 80 and over, pubmed-meshheading:12643457-Blood Pressure, pubmed-meshheading:12643457-Cardiac Output, pubmed-meshheading:12643457-Cardiopulmonary Bypass, pubmed-meshheading:12643457-Female, pubmed-meshheading:12643457-Hospital Mortality, pubmed-meshheading:12643457-Humans, pubmed-meshheading:12643457-Hypotension, pubmed-meshheading:12643457-Infusions, Intravenous, pubmed-meshheading:12643457-Male, pubmed-meshheading:12643457-Middle Aged, pubmed-meshheading:12643457-Paralysis, pubmed-meshheading:12643457-Postoperative Complications, pubmed-meshheading:12643457-Reoperation, pubmed-meshheading:12643457-Syndrome, pubmed-meshheading:12643457-Systole, pubmed-meshheading:12643457-Treatment Outcome, pubmed-meshheading:12643457-Vascular Resistance, pubmed-meshheading:12643457-Vasoconstrictor Agents, pubmed-meshheading:12643457-Vasopressins
pubmed:articleTitle
Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass.
pubmed:affiliation
Division of Cardiovascular and Thoracic Surgery and the Heart Center, Missouri Baptist Medical Center, St. Louis, Missouri, USA.
pubmed:publicationType
Journal Article